Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Cash: 2011-2024

Historic Change in Cash for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to -$12.0 million.

  • Agios Pharmaceuticals' Change in Cash fell 93.00% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$161.0 million, marking a year-over-year decrease of 185.02%. This contributed to the annual value of -$12.0 million for FY2024, which is 76.58% up from last year.
  • Agios Pharmaceuticals' Change in Cash amounted to -$12.0 million in FY2024, which was up 76.58% from -$51.1 million recorded in FY2023.
  • In the past 5 years, Agios Pharmaceuticals' Change in Cash registered a high of $75.7 million during FY2021, and its lowest value of -$63.9 million during FY2022.
  • Its 3-year average for Change in Cash is -$42.3 million, with a median of -$51.1 million in 2023.
  • As far as peak fluctuations go, Agios Pharmaceuticals' Change in Cash spiked by 345.92% in 2020, and later slumped by 184.38% in 2022.
  • Agios Pharmaceuticals' Change in Cash (Yearly) stood at $46.5 million in 2020, then surged by 62.76% to $75.7 million in 2021, then slumped by 184.38% to -$63.9 million in 2022, then grew by 20.06% to -$51.1 million in 2023, then skyrocketed by 76.58% to -$12.0 million in 2024.